Kevin M. Slawin
Kevin M. Slawin
Director, Vanguard Urologic Institute at Memorial Hermann Medical Group
Verified email at - Homepage
Cited by
Cited by
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
JD McConnell, CG Roehrborn, OM Bautista, GL Andriole Jr, CM Dixon, ...
New England Journal of Medicine 349 (25), 2387-2398, 2003
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ...
Jama 279 (19), 1542-1547, 1998
Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial
JB Jemmott III, LS Jemmott, GT Fong
Jama 279 (19), 1529-1536, 1998
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ...
Journal of clinical oncology: official journal of the American Society of …, 2007
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
AJ Stephenson, SF Shariat, MJ Zelefsky, MW Kattan, EB Butler, BS Teh, ...
Jama 291 (11), 1325-1332, 2004
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens
P Swindle, JA Eastham, M Ohori, MW Kattan, T Wheeler, N Maru, ...
The Journal of urology 174 (3), 903-907, 2005
A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to …
WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ...
The Journal of urology 185 (5), 1650-1655, 2011
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging
WJ Catalona, PC Southwick, KM Slawin, AW Partin, MK Brawer, ...
Urology 56 (2), 255-260, 2000
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors
MW Kattan, JA Eastham, TM Wheeler, N Maru, PT Scardino, ...
The Journal of urology 170 (5), 1792-1797, 2003
Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer
JL Gore, SF Shariat, BJ Miles, D Kadmon, N Jiang, TM Wheeler, ...
The Journal of urology 165 (5), 1554-1559, 2001
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer
M Ohori, MW Kattan, H Koh, N Maru, KM Slawin, S Shariat, M Muramoto, ...
The Journal of urology 171 (5), 1844-1849, 2004
Survivin expression is associated with features of biologically aggressive prostate carcinoma
SF Shariat, Y Lotan, H Saboorian, SM Khoddami, CG Roehrborn, ...
Cancer 100 (4), 751-757, 2004
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
SF Shariat, B Andrews, MW Kattan, JH Kim, TM Wheeler, KM Slawin
Urology 58 (6), 1008-1015, 2001
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis
SF Shariat, CG Roehrborn, JD McConnell, S Park, N Alam, TM Wheeler, ...
Journal of Clinical Oncology 25 (4), 349-355, 2007
Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo
ED Crawford, SS Wilson, JD McConnell, KM Slawin, MC Lieber, JA Smith, ...
The Journal of urology 175 (4), 1422-1427, 2006
A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue
SD Mikolajczyk, LS Millar, TJ Wang, HG Rittenhouse, LS Marks, W Song, ...
Cancer research 60 (3), 756-759, 2000
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with …
MW Kattan, SF Shariat, B Andrews, K Zhu, E Canto, K Matsumoto, ...
Journal of Clinical Oncology 21 (19), 3573-3579, 2003
“BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia
SD Mikolajczyk, LS Millar, TJ Wang, HG Rittenhouse, RL Wolfert, ...
Urology 55 (1), 41-45, 2000
Preoperative plasma levels of transforming growth factor beta1 (TGF-β1) strongly predict progression in patients undergoing radical prostatectomy
SF Shariat, M Shalev, A Menesses-Diaz, IY Kim, MW Kattan, TM Wheeler, ...
Journal of Clinical Oncology 19 (11), 2856-2864, 2001
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy
AK Leventis, SF Shariat, MW Kattan, EB Butler, TM Wheeler, KM Slawin
Journal of clinical oncology 19 (4), 1030-1039, 2001
The system can't perform the operation now. Try again later.
Articles 1–20